Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-766-2 | CAS number: 91082-52-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Studies on the toxicokinetics, metabolism and distribution of the UVCB substance are lacking. The constituents of the UVCB substance appear to be readily absorbed from the gastrointestinal tract and the lungs, as evident from the available repeated oral and inhalation dose toxicity studies. The substance is moderately absorbed through the skin. Two major metabolism pathways can be expected for the methylpyridines: hydroxylation of the alkyl groups, with additional oxidation to the corresponding carboxyl compounds, or oxidation of the nitrogen atom. Taking into consideration the low octanol-water partition coefficients of the constituents of the UVCB substance, no bioaccumulation is expected. The carboxyl metabolites of methylpyridines are anticipated to be excreted in the urine as such or conjugated with glycine. The metabolites with oxidation on the nitrogen atom are expected to be excreted in urine without conjugation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Toxicokinetics
Physical-chemical properties
The test substance is a UVCB composed of dimethylpyridines (lutidines), methylpyridines (picolines), trimethylpyridines (collidines), and other pyridine derivatives. The substance is a liquid at room temperature. The molecular weight of the main constituents is 107.15 g/mol, the molecular weight of the further constituents is 93.1 g/mol (picolines) and 121.18 g/mol (collidines). The vapour pressure of the substance is 607 Pa at 25 °C. The log Pow values of the constituents are in the range from 1.09 to 2.08 and the water solubility is >501 g/L at 20 °C. The substance is stable in water at pH 4, 7 and 9.
Absorption
GI absorption
Based on the molecular weight, the log Pow and the water solubility, the substance is likely to be absorbed in the gastrointestinal tract. The absorption is likely to be triggered by passage via passive diffusion, which is favoured for small molecules (molecular weight <200 g/mol) with moderate log P value and high water solubility. Evidence of oral absorption is seen in acute and repeated dose toxicological studies via the oral route of exposure leading to adverse effects in the test animals. However, the extent of adsorption of an orally administered dose cannot be concluded from the reported data.
Dermal absorption
The UVCB substance is a liquid with a high water solubility, a molecular weight of 107.15 g/mol (and a range from 93.1 to 121.18 g/mol) and a vapour pressure of 607 Pa at room temperature. Dermal absorption is favourable for uptake at a molecular weight of <100 g/mol, and the molecular weight of the constituents of the UVCB is only slightly above this value. Based on the water solubility, dermal absorption through the stratum corneum is expected to be limited. Furthermore, the vapour pressure of the substance is 607 Pa, which may result in significant evaporation from the skin prior to absorption. Data on the dermal absorption of the substance are lacking, but the available acute dermal toxicity study demonstrated that the substance was systemically available after a single application, as adverse effects were observed at higher doses. However, the extent of adsorption of a dermally administered dose cannot be concluded from the reported data.
Respiratory absorption
The substance is a liquid that is added as a co-formulant to plant protection products, which are applied by spraying. Furthermore, the substance has a vapour pressure of 607 Pa. It is therefore available for inhalation as an aerosol or vapour. The log P in the range from 1.09 to 2.08 favours absorption across the respiratory tract epithelium by passive diffusion. Furthermore, substances absorbed via the gastrointestinal tract are likely to be absorbed also in the respiratory tract.
Distribution
Data on the distribution of the UVCB substance are lacking. Methyl derivatives of pyridine are anticipated to be distributed to various tissues and organs, such as kidneys, liver, plasma and lungs. They are not likely to be distributed to fat or breast milk, and are unlikely to accumulate in tissues and organs.
Metabolism
Data on the metabolism of the UVCB substance are lacking. Methyl derivatives of pyridine appear to undergo metabolism by cytochrome P450 enzymes. Two major metabolism pathways can be expected for the methyl substituted pyridines: hydroxylation of the alkyl groups, with additional oxidation to the corresponding carboxyl compounds, or oxidation of the nitrogen atom.
Accumulation and excretion
The UVCB substance is water soluble and the log P of the constituents is in the range from 1.09 to 2.08. It is very unlikely that the substance will accumulate in tissues. Methyl derivatives of pyridine are excreted in the urine, and to a lesser extend in exhaled air and faeces. The carboxyl metabolites of methylpyridines are anticipated to be excreted in the urine as such or conjugated with glycine. The metabolites with oxidation on the nitrogen atom are expected to be excreted in urine without conjugation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.